RZLT as of Oct 31 · 15:18 ET
RZLTNasdaqPharmaceutical Preparations
Rezolute, Inc. · Brief
Next report
12 days
Nov 12 · after closeest.Q1 FY27
Expected move
Inputs0 of 8≥ implied
- avg implied
- ±23.6%
- avg realized
- ±4.3%
Nov 7 '24±19.0%▼−2.45%×0.13
Feb 12 '25±10.9%▼−1.03%×0.09
May 13 '25±17.8%▼−4.90%×0.28
Sep 17 '25±13.7%▲+6.36%×0.47
Nov 6 '25±31.0%▲+12.08%×0.39
Q2 FY26±28.3%▲+5.79%×0.20
Q3 FY26±23.5%▲+0.91%×0.04
Sep 24 '26±44.2%▼−1.02%×0.02
quarterimplied−45%0+45%realized×
Sep '26±44.2%▼−1.02%×0.02
Q3 FY26±23.5%▲+0.91%×0.04
Q2 FY26±28.3%▲+5.79%×0.20
Nov '25±31.0%▲+12.08%×0.39
Sep '25±13.7%▲+6.36%×0.47
May '25±17.8%▼−4.90%×0.28
2 older reports
Feb '25±10.9%▼−1.03%×0.09
Nov '24±19.0%▼−2.45%×0.13
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 12 report · est.Bull2 of 3
Bear2 of 4
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
RZLT report sessionSuppliers 1
× = co-movement · max 444dSource: SEC filings · market data
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.